Aida Bibliowicz

Opaganib in COVID-19 pneumonia: Results of a randomized, placebo-controlled Phase 2a trial

M. Levitt, K. Winthrop, H. Minkowitz, 2021, medRxiv.

Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Pneumonia

Andrés F. Agudelo, M. Levitt, N. Assy, 2022, medRxiv.

Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO2 Requirements

G. Rizzardini, A. Mayo, A. Barczyk, 2024, Microorganisms.